Profile
CRG is a premier healthcare-focused investment firm that has managed over $3 billion of institutional capital since inception and its senior investment professionals have led over 70 investments. The firm seeks to commit between $20 to $300 million in each investment across the healthcare spectrum, including: medical devices, biopharmaceuticals, tools & diagnostics, services and information technology. CRG provides growth capital in the form of long-term debt and equity to support innovative, commercial-stage healthcare companies that address large, unmet medical needs. The firm partners with public and private companies to provide flexible financing solutions and world-class support to achieve exceptional growth objectives with minimal dilution. CRG maintains offices in Boulder, New York and Houston. For additional information, please visit www.crglp.com.
Industry
CRG Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Capital Royalty Partners II
|
Private Equity (PE)
|
Healthcare Services
Medical Devices
Life Sciences
|
Series B
Late Stage (Series C+)
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$805 M
|
May 2013
|
|
CRG Partners III
|
Private Equity (PE)
|
Healthcare Services
Medical Devices
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1500 M
|
January 2017
|
|
CRG Partners I LP
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$325 M
|
June 2003
|
|
CRG Partners IV LP
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1400 M
|
November 2017
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.